SP-MHCI-0421-2

SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL

US$169.00

In stock

Description

About SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL

The SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)|SARS-CoV (Severe acute respiratory syndrome coronavirus) Replicase polyprotein 1ab Peptide (IEDB: 28050) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Replicase polyprotein Peptide, H-IPRRNVATL-OH (Uniprot: P0DTD1 aa: 5893-5901) from JPT is produced under strict quality control and quality management.

SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL - Specifications

  • Peptide sequence: H-IPRRNVATL-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Covid-19
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL

References:
Read References with JPT’s Antigen Peptides
SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL has been described in:
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels., medRxiv, 2020 (PMID: 32793919)
Unbiased Screens Show CD8<sup>+</sup> T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein., Immunity, 2020 (PMID: 33128877)

Documentation

Documentation for SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL

Properties

Properties of SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Covid-19
Layout: Freeze-dried in glass vial
Organism: SARS-CoV (Severe acute respiratory syndrome coronavirus), SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Protein Name: Replicase polyprotein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to SARS-CoV-2Replicase polyprotein 1ab 5893-5901, IPRRNVATL

Information Values
Sequence: H-IPRRNVATL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote